FDA Approves New HIV Drug Edurant
The FDA has approved Edurant (rilpivirine) for use in anti-HIV drug cocktails. Edurant is as effective as the popular Sustiva and is in the same NNRTI class of antiretroviral drugs.
Click here to read the full story.
The content has been reported and it will be reviewed by a moderator.
